IFNG and neoplasm: While changes in IFN-γ GMF were only seen at the 96 h timepoint in the TME, IFN-γ+ granulocytes in the spleens of GEM-treated tumor-bearing mice displayed elevated IFN-γ GMFs at all three timepoints (Figure S10Eiii).